
Reset all filters
01 6AbbVie Corporation
Reset all filters
01 42197684
02 22489632
Reset all filters
01 4PALIVIZUMAB
02 2Palivizumab
Reset all filters
01 2Powder and Diluent for Injectable Solution
02 4SOLUTION
Reset all filters
01 42015-08-09
02 22023-06-16
Patent Expiration Date : 2015-08-09
Date Granted : 2000-10-31
Brand Name : SYNAGIS
Patent Number : 2197684
Filing Date : 1995-08-09
Strength per Unit : 50 mg
Dosage Form : Powder and Diluent for Injectable Solution
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2015-08-09
Date Granted : 2000-10-31
Patent Expiration Date : 2015-08-09
Date Granted : 2000-10-31
Brand Name : SYNAGIS
Patent Number : 2197684
Filing Date : 1995-08-09
Strength per Unit : 100 mg
Dosage Form : Powder and Diluent for Injectable Solution
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2015-08-09
Date Granted : 2000-10-31
Patent Expiration Date : 2015-08-09
Date Granted : 2000-10-31
Brand Name : SYNAGIS
Patent Number : 2197684
Filing Date : 1995-08-09
Strength per Unit : 50mg / 0.5 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAMUSCULAR
Patent Expiration Date : 2015-08-09
Date Granted : 2000-10-31
Patent Expiration Date : 2023-06-16
Date Granted : 2015-08-18
Brand Name : SYNAGIS
Patent Number : 2489632
Filing Date : 2003-06-16
Strength per Unit : 50mg / 0.5 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAMUSCULAR
Patent Expiration Date : 2023-06-16
Date Granted : 2015-08-18
Patent Expiration Date : 2015-08-09
Date Granted : 2000-10-31
Brand Name : SYNAGIS
Patent Number : 2197684
Filing Date : 1995-08-09
Strength per Unit : 100mg / 1 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAMUSCULAR
Patent Expiration Date : 2015-08-09
Date Granted : 2000-10-31
Patent Expiration Date : 2023-06-16
Date Granted : 2015-08-18
Brand Name : SYNAGIS
Patent Number : 2489632
Filing Date : 2003-06-16
Strength per Unit : 100mg / 1 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAMUSCULAR
Patent Expiration Date : 2023-06-16
Date Granted : 2015-08-18